US Stock MarketDetailed Quotes

TLSI TriSalus Life Sciences

Watchlist
  • 5.650
  • +0.120+2.17%
Close Feb 14 16:00 ET
  • 5.650
  • 0.0000.00%
Post 20:01 ET
172.29MMarket Cap-2.95P/E (TTM)

TriSalus Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TriSalus Life Sciences Q4 2024 Estimates Date

Currency：USDMar 27, 2025

Estimate YoY
Revenue
8.22M
+43.76%
EPS
-0.32
+79.65%
Analyst Rating
Strong Buy

Feb 14, 2025

TriSalus Life Sciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.161M--
Mar 27, 20252024/Q4-- / 8.224M--
Nov 14, 20242024/Q37.349M / 7.373M--
Aug 15, 20242024/Q27.364M / 6.894M--
May 15, 20242024/Q16.457M / 6.179M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.161M--
Mar 27, 20252024/Q4-- / 8.224M--
Nov 14, 20242024/Q37.349M / 7.373M--
Aug 15, 20242024/Q27.364M / 6.894M--
May 15, 20242024/Q16.457M / 6.179M--

Unlock Free Earnings Estimates

TriSalus Life Sciences Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 21:37

  • 10-Q: Quarterly report

    Aug 15, 2024 04:12

  • 10-Q: Q1 2024 Earnings Report

    May 15, 2024 21:10

  • TriSalus Life Sciences | 10-K: FY2023 Annual Report

    Apr 12, 2024 04:40

    • Read more

    Trending Stocks
    Warren Buffett Portfolio Warren Buffett Portfolio

    Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

    Symbol Mini Chart % Chg
    Citigroup
    C
    +3.06%
    Bank of America
    BAC
    +1.36%
    Apple
    AAPL
    +1.27%
    American Express
    AXP
    +1.15%
    Chevron
    CVX
    +0.76%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 14, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data